AAAAAA

   
Results: 1-22 |
Results: 22
A pharmacokinetic interpretation of increasing concentrations of DEHP in haemodialysed patients
Authors: Dine, T Luyckx, M Gressier, B Brunet, C Souhait, J Nogarede, S Vanpoucke, J Courbon, F Plusquellec, Y Houin, G
Citation: T. Dine et al., A pharmacokinetic interpretation of increasing concentrations of DEHP in haemodialysed patients, MED ENG PHY, 22(3), 2000, pp. 157-165
Pharmacokinetics of reboxetine in volunteers with hepatic impairment
Authors: Tran, A Laneury, JP Duchene, P Jannuzzo, MG Fleishaker, JC Houin, G Rampal, P
Citation: A. Tran et al., Pharmacokinetics of reboxetine in volunteers with hepatic impairment, CLIN DRUG I, 19(6), 2000, pp. 473-477
Pharmacokinetics of reboxetine in healthy, elderly volunteers
Authors: Bergmann, JF Laneury, JP Duchene, P Fleishaker, JC Houin, G Segrestaa, JM
Citation: Jf. Bergmann et al., Pharmacokinetics of reboxetine in healthy, elderly volunteers, EUR J DRUG, 25(3-4), 2000, pp. 195-198
Pharmacokinetics of single-dose reboxetine in volunteers with renal insufficiency
Authors: Coulomb, F Ducret, F Laneury, JP Fiorentini, F Poggesi, I Jannuzzo, MG Fleishaker, JC Houin, G Duchene, P
Citation: F. Coulomb et al., Pharmacokinetics of single-dose reboxetine in volunteers with renal insufficiency, J CLIN PHAR, 40(5), 2000, pp. 482-487
Pharmacodynamic study of low molecular weight dermatan sulphate (Desmin) after a single subcutaneous administration in patients with renal insufficiency
Authors: Saivin, S Boneu, B Ducret, F Pourrat, J Palazzini, E Zamboni, W Duchene, P Houin, G
Citation: S. Saivin et al., Pharmacodynamic study of low molecular weight dermatan sulphate (Desmin) after a single subcutaneous administration in patients with renal insufficiency, ARZNEI-FOR, 50(9), 2000, pp. 821-826
Pharmacokinetics and bioequivalence of two trimebutine formulations in healthy volunteers using desmethyl-trimebutine levels
Authors: Saivin, S Lavit, M Michel, F Labaune, JP Martin, A Cahiez, G Donazzolo, C Chomard, JM Houin, G
Citation: S. Saivin et al., Pharmacokinetics and bioequivalence of two trimebutine formulations in healthy volunteers using desmethyl-trimebutine levels, ARZNEI-FOR, 50(8), 2000, pp. 717-721
Determination of trimebutine and desmethyl-trimebutine in human plasma by HPLC
Authors: Lavit, M Saivin, S Boudra, H Michel, F Martin, A Cahiez, G Labaune, JP Chomard, JM Houin, G
Citation: M. Lavit et al., Determination of trimebutine and desmethyl-trimebutine in human plasma by HPLC, ARZNEI-FOR, 50(7), 2000, pp. 640-644
Synthesis of methylamino-2-phenyl-2-butyl-3,4,5-trimethoxybenzoate, the main bioactive metabolite of trimebutine maleate
Authors: Martin, A Figadere, B Saivin, S Houin, G Chomard, JM Cahiez, G
Citation: A. Martin et al., Synthesis of methylamino-2-phenyl-2-butyl-3,4,5-trimethoxybenzoate, the main bioactive metabolite of trimebutine maleate, ARZNEI-FOR, 50(6), 2000, pp. 544-549
Effect of polyoxyl 35 castor oil and polysorbate 80 on the intestinal absorption of digoxin in vitro
Authors: Cornaire, G Woodley, JF Saivin, S Legendre, JY Decourt, S Cloarec, A Houin, G
Citation: G. Cornaire et al., Effect of polyoxyl 35 castor oil and polysorbate 80 on the intestinal absorption of digoxin in vitro, ARZNEI-FOR, 50(6), 2000, pp. 576-579
Pharmacokinetics, metabolism and excretion of megazol in a Trypanosoma brucei gambiense primate model of human African trypanosomiasis - Preliminary study
Authors: Enanga, B Ndong, JMM Boudra, H Debrauwer, L Dubreuil, G Bouteille, B Chauviere, G Labat, C Dumas, M Perie, J Houin, G
Citation: B. Enanga et al., Pharmacokinetics, metabolism and excretion of megazol in a Trypanosoma brucei gambiense primate model of human African trypanosomiasis - Preliminary study, ARZNEI-FOR, 50(2), 2000, pp. 158-162
In vivo study of percutaneous absorption of 4-chloroaniline using microdialysis in the rat
Authors: El Marbouh, L Arellano, C Philibert, C Evrard, P Poey, J Houin, G
Citation: L. El Marbouh et al., In vivo study of percutaneous absorption of 4-chloroaniline using microdialysis in the rat, ARZNEI-FOR, 50(11), 2000, pp. 1033-1036
A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption
Authors: Plusquellec, Y Efthymiopoulos, C Duthil, P Houin, G
Citation: Y. Plusquellec et al., A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption, MED ENG PHY, 21(8), 1999, pp. 525-532
The roles of P-glycoprotein and intracellullar metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac
Authors: Bouer, R Barthe, L Philibert, C Tournaire, C Woodley, J Houin, G
Citation: R. Bouer et al., The roles of P-glycoprotein and intracellullar metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac, FUN CL PHAR, 13(4), 1999, pp. 494-500
Gastrointestinal absorption of drugs: methods and studies
Authors: Barthe, L Woodley, J Houin, G
Citation: L. Barthe et al., Gastrointestinal absorption of drugs: methods and studies, FUN CL PHAR, 13(2), 1999, pp. 154-168
Continuous versus intermittent cefepime infusion in critical care patients. Preliminary findings.
Authors: Georges, B Archambaud, M Saivin, S Decun, JF Cougot, P Mazerolles, M Andrieu, P Suc, C Houin, G Chabanon, G Virenque, C
Citation: B. Georges et al., Continuous versus intermittent cefepime infusion in critical care patients. Preliminary findings., PATH BIOL, 47(5), 1999, pp. 483-485
A pharmacokinetic model for alpha interferon administered subcutaneously
Authors: Chatelut, E Rostaing, L Gregoire, N Payen, JL Pujol, A Izopet, J Houin, G Canal, P
Citation: E. Chatelut et al., A pharmacokinetic model for alpha interferon administered subcutaneously, BR J CL PH, 47(4), 1999, pp. 365-371
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 Part III: Pharmacokinetics, metabolism, dose dependancy and gender effect after single or repeated administration to human healthy volunteers
Authors: Duchene, P Laneury, JP Tran, G Ladure, P Ollivier, P Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 Part III: Pharmacokinetics, metabolism, dose dependancy and gender effect after single or repeated administration to human healthy volunteers, ARZNEI-FOR, 49(8), 1999, pp. 699-704
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 - Part II: Pharmacokinetics in primates after repeated oral or single intravenous administration
Authors: Duchene, P Guidicelli, MD Tran, G Ladure, P Ollivier, R Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 - Part II: Pharmacokinetics in primates after repeated oral or single intravenous administration, ARZNEI-FOR, 49(7), 1999, pp. 608-611
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 part 1: Pharmacokinetics and tissular distribution in Sprague-Dawley rats
Authors: Duchene, P Tran, G Ladure, P Ollivier, R Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 part 1: Pharmacokinetics and tissular distribution in Sprague-Dawley rats, ARZNEI-FOR, 49(6), 1999, pp. 504-508
Pharmacokinetics, metabolism and excretion of megazol, a new potent trypanocidal drug in animals
Authors: Enanga, B Boudra, H Chauviere, G Labat, C Bouteille, B Dumas, M Houin, G
Citation: B. Enanga et al., Pharmacokinetics, metabolism and excretion of megazol, a new potent trypanocidal drug in animals, ARZNEI-FOR, 49(5), 1999, pp. 441-447
Microdialysis of melatonin in the confluens sinuum of the rat following quantification by gas chromatography-mass spectrometry in the negative chemical ion mode
Authors: Boudra, H Saivin, S Delagrange, P Malmary, MF Genissel, P Houin, G
Citation: H. Boudra et al., Microdialysis of melatonin in the confluens sinuum of the rat following quantification by gas chromatography-mass spectrometry in the negative chemical ion mode, ARZNEI-FOR, 49(10), 1999, pp. 849-852
Relation between unbound plasma concentrations and toxicity in a prolongedoral etoposide schedule
Authors: Perdaems, N Bachaud, JM Rouzaud, P Murris-Espin, M Hermant, C Mihura, J Lochon, I Houin, G Canal, P Chatelut, E
Citation: N. Perdaems et al., Relation between unbound plasma concentrations and toxicity in a prolongedoral etoposide schedule, EUR J CL PH, 54(9-10), 1998, pp. 677-683
Risultati: 1-22 |